Clostridium Difficile

Clostridium difficile, or C. difficile (a gram-positive anaerobic bacterium), is now recognized as the major causative agent of colitis (inflammation of the colon) and diarrhea that may occur following antibiotic intake. C. difficile infection represents one of the most common hospital infections around the world.

A wide range of conditions is associated with C. difficile infection. The most common symptom is either mild colitis, or simple diarrhea that is watery and contains mucus but not blood. Diarrhea usually stops when antibiotics are discontinued. C. difficile can also cause non-specific colitis suggestive of other intestinal bacterial infections. The most serious manifestation of C. difficile infection, fulminant colitis (severe sudden inflammation of the colon), is frequently associated with very serious complications.

C. difficile may complicate the course of ulcerative colitis or Crohn’s disease and it is responsible for a significant occurence of diarrhea in AIDS patients. In this case, patients develop the typical symptoms of C. difficile colitis, including diarrhea, abdominal pain, and fever reminiscent of exacerbation of inflammatory bowel disease.

Therapy of C. difficile is directed against eradication of the microorganism from the colonic microflora. Most patients respond well to antibiotic treatment. However, some patients do not respond despite aggressive medical therapy and require surgical intervention.

More Information

Go to Publication Library for the Clostridium Difficile Infection IFFGD Factsheet No. 167.

Share this page
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Topics of this article
Was this article helpful?

IFFGD is a nonprofit education and research organization. Our mission is to inform, assist, and support people affected by gastrointestinal disorders.

Our original content is authored specifically for IFFGD readers, in response to your questions and concerns.

If you found this article helpful, please consider supporting IFFGD with a small tax-deductible donation.

Related Information
Tina

Tina’s Journey with Functional GI Disorders By Tina Aswani-Omprakash April 1, 2021 I had struggled with severe constipation all my life until I suddenly didn’t.

Read More »
2021 Advocacy Education Program

Session ONE: Finding Help Through Support Groups on Facebook Session TWO: In-person and Online Support Groups Session THREE: Developing a Comprehensive Support System Session FOUR: Advocacy

Read More »
Personal Stories
Tina

Tina’s Journey with Functional GI Disorders By Tina Aswani-Omprakash April 1, 2021 I had struggled with severe constipation all my life until I suddenly didn’t.

Read More »
2021 Advocacy Education Program

Session ONE: Finding Help Through Support Groups on Facebook Session TWO: In-person and Online Support Groups Session THREE: Developing a Comprehensive Support System Session FOUR: Advocacy

Read More »